Active Ingredient: BREMELANOTIDE ACETATE
Proprietary Name: VYLEESI (AUTOINJECTOR)
Dosage Form; Route of Administration: SOLUTION; SUBCUTANEOUS
Strength: EQ 1.75MG BASE/0.3ML (EQ 1.75MG BASE/0.3 ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N210557
Product Number: 001
Approval Date: Jun 21, 2019
Applicant Holder Full Name: PALATIN TECHNOLOGIES INC
Marketing Status:
Prescription
Patent and Exclusivity Information
